Atrial Fibrillation Significantly Increases Mortality Risk in Severe COVID-19 Cases.
Nikhil Prasad Fact checked by:Thailand Medical News Team May 28, 2024 6 months, 4 weeks, 5 hours, 35 minutes ago
COVID-19 News: The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has had a profound impact on global health, significantly altering morbidity and mortality profiles. While the pandemic has been challenging for everyone, those with pre-existing health conditions, especially cardiovascular diseases, have faced heightened risks. A recent study from Poland's Medical University of Lodz, Bieganski Hospital, and Copernicus Memorial Hospital that is covered in this
COVID-19 News report, sheds light on the specific dangers faced by COVID-19 patients with atrial fibrillation (AF).
Atrial Fibrillation Significantly Increases Mortality Risk in Severe COVID-19 Cases
Understanding the Study
The study analyzed 199 patients, with a median age of 70 years, hospitalized due to severe COVID-19 between November 2020 and February 2021. Among these patients, 68 had a history of AF, while 51 developed AF during their hospital stay. The primary aim was to investigate the link between AF and mortality rates in these severe cases of COVID-19.
Key Findings - Mortality Rates and AF
The overall mortality rate within 90 days of hospital admission was alarmingly high at 41%. Patients with a history of AF or who developed AF during hospitalization were at a significantly higher risk of death. Notably, those with permanent and persistent AF faced the greatest danger. The study found that AF, particularly in its permanent and persistent forms, was an independent predictor of mortality.
Clinical Characteristics of Non-Survivors
Non-survivors in the study were generally older and had higher levels of inflammation markers such as CRP, WBC, procalcitonin, and IL-6. They also exhibited elevated NT-proBNP and D-dimer levels on the first day of hospitalization, along with poorer kidney function and lower left ventricular ejection fraction. These indicators highlight the severe health challenges faced by these patients.
Implications of the Study - AF as a Prognostic Marker
The presence of AF, whether as a pre-existing condition or developed during hospitalization, was a clear marker of poor prognosis. This finding aligns with other studies that have shown cardiovascular diseases significantly worsen the outcomes of COVID-19. In this study, 34% of patients had a history of AF, and these individuals faced a notably higher risk of death.
Different Forms of AF
The study's detailed analysis revealed that the type of AF matters significantly. Patients with persistent or permanent AF had the highest mortality rates. Persistent AF had a mortality rate of 67%, while permanent AF was even higher at 68%. This contrasted with a 44% mortality rate for paroxysmal AF.
Broader Context: Cardiovascular Disease and COVID-19
The broader context of cardiovascular disease (CVD) in the COVID-19 pandemic is crucial. A meta-analysis of over 300,000 COVID-
19 patients found that those with CVD had a four-fold higher risk of mortality. The interplay between COVID-19 and heart conditions has been a significant focus of research, as the virus can cause thromboembolic disease, myocarditis, heart failure, and other serious cardiovascular complications.
Univariate Analysis
The study employed univariate analysis to identify predictors of death. Besides age and AF, higher levels of NT-proBNP, white blood cells, and poorer kidney function emerged as significant predictors. These findings underscore the multifaceted health challenges in severe COVID-19 cases.
Multivariate Logistic Regression Models
Three multivariable logistic regression models were used to identify independent predictors of death. Persistent and permanent AF were consistently highlighted as significant risk factors, along with age and biomarkers like NT-proBNP and white blood cell levels. These models provide a robust framework for understanding the specific risks in severe COVID-19 patients.
Conclusion
This comprehensive study highlights the critical impact of atrial fibrillation on mortality rates in severe COVID-19 cases. Persistent and permanent AF significantly increase the risk of death, making it a vital factor for clinicians to consider when assessing and treating COVID-19 patients. The findings underscore the need for heightened awareness and proactive management of cardiovascular conditions in the context of the ongoing pandemic.
Future Directions
Given the study's findings, there is a clear need for further research into the mechanisms linking AF and COVID-19 mortality. Additionally, exploring potential therapeutic strategies to mitigate these risks could be life-saving for patients with severe COVID-19. Understanding and addressing the cardiovascular implications of COVID-19 remains a critical area of focus as the world continues to grapple with the pandemic.
The study findings were published in the peer reviewed Journal of Clinical Medicine.
https://www.mdpi.com/2077-0383/13/11/3112
For the latest
COVID-19 News, keep on logging to Thailand Medical News.
Read Also:
https://www.thailandmedical.news/news/study-finds-that-regular-use-of-fish-oil-supplements-might-be-a-risk-factor-for-atrial-fibrillation-and-stroke
https://www.thailandmedical.news/news/breaking-45-percent-of-individuals-who-get-hospitalized-for-heart-arrhythmia-typically-die-within-the-next-ten-years
https://www.thailandmedical.news/news/italian-and-swiss-researchers-warn-that-covid-19-mrna-vaccines-can-lead-to-arrhythmias
https://www.thailandmedical.news/news/mechanisms-that-trigger-cardiac-arrhythmia-in-covid-19
https://www.thailandmedical.news/news/medical-news-researchers-claim-that-fibrinaloid-microclots-could-be-behind-atrial-fibrillation-relevant-for-sars-cov-2-context
Share
Tweet
Share
